Thrombotic microangiopathy (TMA) is a condition characterized by thrombocytopenia and
microangiopathic hemolytic anemia (MAHA) with varying degrees of organ damage in the …

The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ …

Background Hemolytic uremic syndrome (HUS) is a leading cause of acute kidney injury in
children. Although international guidelines emphasize comprehensive evaluation and …

Background: Atypical hemolytic uremic syndrome (aHUS), an important cause of acute
kidney injury (AKI), is characterized by dysregulation of the alternative complement pathway …

The advent of next gene sequencing technology has led to the publication of a profusion of
papers on monogenic contributions to pediatric kidney disorders. It started with the discovery …

Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening thrombotic
microangiopathy. Definitive biomarkers for disease diagnosis and activity remain elusive …

Background Atypical hemolytic uremic syndrome (aHUS) is characterized by
microangiopathic hemolytic anemia, thrombocytopenia and kidney injury caused by a …

Background The etiology of atypical hemolytic uremic syndrome (aHUS) is unknown in 30–
40% of patients. Anti-factor B (FB) antibodies are reported in C3 glomerulopathy (C3G) and …

Objectives Atypical hemolytic uremic syndrome (aHUS) is characterized by a triad of
thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure resulting …

Thrombotic microangiopathy (TMA) is a triad of microangiopathic hemolytic anemia,
thrombocytopenia, and end-organ ischaemic damage. The primary mechanism involved is …